HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

Conference contribution


Publication Details

Author(s): Stickel F, Lutz P, Buch S, Fischer J, Rausch V, Silva I, Rosendahl J, Nischalke HD, Krawczyk M, Lammert F, Casper M, Zopf S, Marhenke S, Vogel A, Eyer F, Von Felden J, Gotthardt D, Weiss KH, Spengler U, Mueller S, Canbay A, Baselli GA, Valenti L, Mcquillin A, Berg T, Hampe J, Morgan M
Publisher: ELSEVIER SCIENCE BV
Publishing place: AMSTERDAM
Publication year: 2019
Conference Proceedings Title: JOURNAL OF HEPATOLOGY
Pages range: E109-E110
ISSN: 0168-8278


FAU Authors / FAU Editors

Zopf, Steffen PD Dr.
Medizinische Fakultät


External institutions with authors

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Martin-Luther-Universität Halle-Wittenberg (MLU)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Rheinische Friedrich-Wilhelms-Universität Bonn
Ruprecht-Karls-Universität Heidelberg
Technische Universität München (TUM)
Universität des Saarlandes (UdS)
Universitätsklinikum Carl Gustav Carus Dresden
Universitätsklinikum Hamburg-Eppendorf (UKE)
Universitätsklinikum Heidelberg
Universitätsklinikum Leipzig
Universitätsklinikum Magdeburg A.ö.R.
Universitätsspital Zürich (USZ)
University College London (UCL)


How to cite

APA:
Stickel, F., Lutz, P., Buch, S., Fischer, J., Rausch, V., Silva, I.,... Morgan, M. (2019). HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis. In JOURNAL OF HEPATOLOGY (pp. E109-E110). Vienna, AT: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:
Stickel, Felix, et al. "HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis." Proceedings of the International Liver Congress, Vienna AMSTERDAM: ELSEVIER SCIENCE BV, 2019. E109-E110.

BibTeX: 

Last updated on 2019-09-05 at 08:23